Detection and analysis of long noncoding RNA expression profiles related to epithelial–mesenchymal transition in keloids
暂无分享,去创建一个
[1] P. Naik. Novel targets and therapies for keloid , 2021, Clincal and Experimental Dermatology.
[2] Xingxu Zhao,et al. LncRNA GAS5 Competitively Combined With miR-21 Regulates PTEN and Influences EMT of Peritoneal Mesothelial Cells via Wnt/β-Catenin Signaling Pathway , 2021, Frontiers in Physiology.
[3] Jinzhong Chen,et al. Identification of Key lncRNA–mRNA Pairs and Functional lncRNAs in Breast Cancer by Integrative Analysis of TCGA Data , 2021, Frontiers in Genetics.
[4] Zhijun Zhang,et al. Circulating lncRNA UCA1 and lncRNA PGM5-AS1 act as potential diagnostic biomarkers for early-stage colorectal cancer , 2021, Bioscience reports.
[5] Yi Liu,et al. LncRNA‐ATB regulates epithelial‐mesenchymal transition progression in pulmonary fibrosis via sponging miR‐29b‐2‐5p and miR‐34c‐3p , 2021, Journal of cellular and molecular medicine.
[6] M. Fear,et al. The epigenetics of keloids , 2021, Experimental dermatology.
[7] D. Gu,et al. LncRNA THAP9-AS1 accelerates cell growth of esophageal squamous cell carcinoma through sponging miR-335-5p to regulate SGMS2. , 2021, Pathology, research and practice.
[8] Joanna Kałafut,et al. Decoding LncRNAs , 2021, Cancers.
[9] Ying-ying Dong,et al. Identifying an lncRNA-Related ceRNA Network to Reveal Novel Targets for a Cutaneous Squamous Cell Carcinoma , 2021, Biology.
[10] D. Yin,et al. Progress of non-coding RNAs in triple-negative breast cancer. , 2021 .
[11] K. Fang,et al. lncRNA FGD5-AS1 promotes breast cancer progression by regulating the hsa-miR-195-5p/NUAK2 axis , 2021, Molecular medicine reports.
[12] Expression of Concern: Long non coding RNA FAM3D-AS1 inhibits development of colorectal cancer through NF-kB signaling pathway , 2021, Bioscience Reports.
[13] Ping Chen,et al. LncRNA SNHG12 promotes proliferation and epithelial mesenchymal transition in hepatocellular carcinoma through targeting HEG1 via miR-516a-5p. , 2021, Cellular signalling.
[14] Xintao Li,et al. LncRNA NORAD, sponging miR-363-3p, promotes invasion and EMT by upregulating PEAK1 and activating the ERK signaling pathway in NSCLC cells , 2021, Journal of Bioenergetics and Biomembranes.
[15] Wenjian Chen,et al. lncRNA LINC00963 downregulation regulates colorectal cancer tumorigenesis and progression via the miR‑10b/FGF13 axis. , 2021, Molecular Medicine Reports.
[16] Guodong Wu,et al. LncRNA WT1-AS downregulates lncRNA UCA1 to suppress non-small cell lung cancer and predicts poor survival , 2021, BMC cancer.
[17] Liang Zhou,et al. Long Non-Coding RNA LOC648987 Promotes Proliferation and Metastasis of Renal Cell Carcinoma by Regulating Epithelial-Mesenchymal Transition , 2021, Technology in cancer research & treatment.
[18] Hongsheng Liu,et al. LncRNA PART1 promotes cell proliferation and progression in non‐small‐cell lung cancer cells via sponging miR‐17‐5p , 2020, Journal of cellular biochemistry.
[19] Lingling Sun,et al. lncRNA EZR-AS1 knockdown represses proliferation, migration and invasion of cSCC via the PI3K/AKT signaling pathway , 2020, Molecular medicine reports.
[20] Lei Shi,et al. LncRNA ZFAS1, as a poor prognostic indicator, promotes cell proliferation and epithelial-mesenchymal transition in endometrial carcinoma. , 2020, Personalized medicine.
[21] Y. Zhang,et al. LncRNA UCA1 regulates cervical cancer survival and EMT occurrence by targeting miR-155. , 2020, European review for medical and pharmacological sciences.
[22] Hui Sun,et al. Long non-coding RNA LINC01116 accelerates the progression of keloid formation by regulating miR-203/SMAD5 axis. , 2020, Burns : journal of the International Society for Burn Injuries.
[23] A. Modarressi,et al. The renin‐angiotensin system in cutaneous hypertrophic scar and keloid formation , 2020, Experimental dermatology.
[24] Ling He,et al. Knockdown of long non-coding RNA SLC8A1-AS1 attenuates cell invasion and migration in glioma via suppression of Wnt/β-catenin signaling pathways , 2020, Brain Research Bulletin.
[25] Kou-Juey Wu,et al. Hypoxia-induced lncRNA RP11-390F4.3 promotes epithelial-mesenchymal transition (EMT) and metastasis through upregulating EMT regulators. , 2020, Cancer letters.
[26] Si-Yu Liu,et al. Epithelial–mesenchymal transition in the formation of hypertrophic scars and keloids , 2019, Journal of cellular physiology.
[27] Yun-chang Yuan,et al. LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis. , 2019, The international journal of biochemistry & cell biology.
[28] Hong Jiang,et al. Livin is involved in TGF-β1-induced renal tubular epithelial-mesenchymal transition through lncRNA-ATB. , 2019, Annals of translational medicine.
[29] D. Liu,et al. Detection and Analysis of the Hedgehog Signaling Pathway-Related Long Non-Coding RNA (lncRNA) Expression Profiles in Keloid , 2018, Medical science monitor : international medical journal of experimental and clinical research.
[30] Di Chen,et al. Enah overexpression is correlated with poor survival and aggressive phenotype in gastric cancer , 2018, Cell Death & Disease.
[31] Yi Liu,et al. Long non-coding RNA-ATB promotes EMT during silica-induced pulmonary fibrosis by competitively binding miR-200c. , 2018, Biochimica et biophysica acta. Molecular basis of disease.
[32] Fan-jie Liu,et al. The significance of ENAH in carcinogenesis and prognosis in gastric cancer , 2017, Oncotarget.
[33] Jian-hui Chen,et al. Overexpression of lncRNA HOXA11-AS promotes cell epithelial–mesenchymal transition by repressing miR-200b in non-small cell lung cancer , 2017, Cancer Cell International.
[34] B. Wang,et al. Identification of skin-related lncRNAs as potential biomarkers that are involved in Wnt pathways in keloids , 2017, Oncotarget.
[35] S. Egawa,et al. Examination of Epithelial Mesenchymal Transition in Keloid Tissues and Possibility of Keloid Therapy Target , 2016, Plastic and reconstructive surgery. Global open.
[36] Shichao Han,et al. Knockdown of lncRNA-ATB suppresses autocrine secretion of TGF-β2 by targeting ZNF217 via miR-200c in keloid fibroblasts , 2016, Scientific Reports.
[37] Zhaoshen Li,et al. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer , 2016, Digestive Diseases and Sciences.
[38] Xiao Long,et al. LncRNA expression profiles and validation in keloid and normal skin tissue. , 2015, International journal of oncology.
[39] R. Zhao,et al. Keloid-derived keratinocytes acquire a fibroblast-like appearance and an enhanced invasive capacity in a hypoxic microenvironment in vitro , 2015, International journal of molecular medicine.
[40] R. Fridman,et al. Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer , 2015, Breast Cancer Research and Treatment.
[41] Yan Zhang,et al. Discoidin domain receptor 2 (DDR2) promotes breast cancer cell metastasis and the mechanism implicates epithelial–mesenchymal transition programme under hypoxia , 2014, The Journal of pathology.
[42] Yuan Lin,et al. Expression of cytoskeleton regulatory protein Mena in human hepatocellular carcinoma and its prognostic significance , 2014, Medical Oncology.
[43] M. Kretz,et al. The non‐coding skin: Exploring the roles of long non‐coding RNAs in epidermal homeostasis and disease , 2013, BioEssays : news and reviews in molecular, cellular and developmental biology.
[44] G. Hoxhaj,et al. MENA Is a Transcriptional Target of the Wnt/Beta-Catenin Pathway , 2012, PloS one.
[45] L. Azamfirei,et al. Mena, a new available marker in tumors of salivary glands? , 2012, European journal of histochemistry : EJH.
[46] I. Badiola,et al. Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability. , 2011, Oncology reports.
[47] L. Walsh,et al. Discoidin domain receptor 2 is a critical regulator of epithelial-mesenchymal transition. , 2011, Matrix biology : journal of the International Society for Matrix Biology.
[48] Robert A. Weinberg,et al. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.
[49] M. Mottolese,et al. The Cytoskeleton Regulatory Protein hMena (ENAH) Is Overexpressed in Human Benign Breast Lesions with High Risk of Transformation and Human Epidermal Growth Factor Receptor-2–Positive/Hormonal Receptor–Negative Tumors , 2006, Clinical Cancer Research.
[50] B. Leitinger. Molecular Analysis of Collagen Binding by the Human Discoidin Domain Receptors, DDR1 and DDR2 , 2003, The Journal of Biological Chemistry.
[51] S. Friedman,et al. Discoidin Domain Receptor 2 Regulates Fibroblast Proliferation and Migration through the Extracellular Matrix in Association with Transcriptional Activation of Matrix Metalloproteinase-2* , 2002, The Journal of Biological Chemistry.
[52] T. Gibson. Keloids , 1968 .
[53] A. Maderal,et al. Keloids and Hypertrophic Scars: Pathophysiology, Classification, and Treatment , 2017, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[54] M. Higashi,et al. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression. , 2009, International journal of oncology.
[55] S. Gurzu,et al. The immunohistochemical aspects of protein Mena in cervical lesions. , 2009, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.